SAB Biotherapeutics, Inc.SABSNASDAQ
Loading
Cash spent on acquiring or upgrading physical assets
Latest
$-933155.00
↑ 77% vs avg
Percentile
P50
Within normal range
Streak
2 yr
Consecutive declineContracting
Average
$-3.99M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | $-933155.00 | -176.7% |
| 2024 | $-337262.00 | -71.1% |
| 2023 | $-197154.00 | +90.9% |
| 2022 | $-2.17M | +80.2% |
| 2021 | $-10.94M | +14.0% |
| 2020 | $-12.73M | -1991.5% |
| 2019 | $-608748.00 | - |